All content for Foundation Fighting Blindness is the property of Foundation Fighting Blindness and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Foundation funded preclinical studies for the approach and launched Opus.
Eye on the Cure Podcast | Episode 91: Dr. George Magrath
Foundation Fighting Blindness
22 minutes 19 seconds
2 months ago
Eye on the Cure Podcast | Episode 91: Dr. George Magrath
September 5, 2025. Dr. George Magrath, CEO of Opus Genetics, talks with host Ben Shaberman about the company's evolution and progress in clinically developing gene therapies for several inherited retinal diseases including those caused by mutations in the genes: LCA5, BEST1, RHO, RDH12, MERTK, NMNAT1, and CNGB1.
Foundation Fighting Blindness
The Foundation funded preclinical studies for the approach and launched Opus.
